Pathogenic p62/SQSTM1 mutations impair energy metabolism through limitation of mitochondrial substrates

Fernando Bartolome, Noemi Esteras, Angeles Martin-Requero, Claire Boutoleau-Bretonniere, Martine Vercelletto, Audrey Gabelle, Isabelle Le Ber, Tadashi Honda, Albena T. Dinkova-Kostova, John Hardy, Eva Carro, Andrey Y. Abramov

Research output: Contribution to journalArticle

Abstract

Abnormal mitochondrial function has been found in patients with frontotemporal dementia (FTD) and amyotrophic lateral sclerosis (ALS). Mutations in the p62 gene (also known as SQSTM1) which encodes the p62 protein have been reported in both disorders supporting the idea of an ALS/FTD continuum. In this work the role of p62 in energy metabolism was studied in fibroblasts from FTD patients carrying two independent pathogenic mutations in the p62 gene, and in a p62-knock-down (p62 KD) human dopaminergic neuroblastoma cell line (SH-SY5Y). We found that p62 deficiency is associated with inhibited complex I mitochondrial respiration due to lack of NADH for the electron transport chain. This deficiency was also associated with increased levels of NADPH reflecting a higher activation of pentose phosphate pathway as this is accompanied with higher cytosolic reduced glutathione (GSH) levels. Complex I inhibition resulted in lower mitochondrial membrane potential and higher cytosolic ROS production. Pharmacological activation of transcription factor Nrf2 increased mitochondrial NADH levels and restored mitochondrial membrane potential in p62-deficient cells. Our results suggest that the phenotype is caused by a loss-of-function effect, because similar alterations were found both in the mutant fibroblasts and the p62 KD model. These findings highlight the implication of energy metabolism in pathophysiological events associated with p62 deficiency.

Original languageEnglish (US)
Article number1666
JournalScientific Reports
Volume7
Issue number1
DOIs
StatePublished - Dec 1 2017
Externally publishedYes

Fingerprint

Mitochondrial Membrane Potential
NAD
Energy Metabolism
Fibroblasts
Pentose Phosphate Pathway
Frontotemporal Dementia
Mutation
Electron Transport
Neuroblastoma
NADP
Genes
Glutathione
Respiration
Transcription Factors
Pharmacology
Phenotype
Cell Line
Proteins
Frontotemporal Dementia With Motor Neuron Disease
Inhibition (Psychology)

ASJC Scopus subject areas

  • General

Cite this

Bartolome, F., Esteras, N., Martin-Requero, A., Boutoleau-Bretonniere, C., Vercelletto, M., Gabelle, A., ... Abramov, A. Y. (2017). Pathogenic p62/SQSTM1 mutations impair energy metabolism through limitation of mitochondrial substrates. Scientific Reports, 7(1), [1666]. https://doi.org/10.1038/s41598-017-01678-4

Pathogenic p62/SQSTM1 mutations impair energy metabolism through limitation of mitochondrial substrates. / Bartolome, Fernando; Esteras, Noemi; Martin-Requero, Angeles; Boutoleau-Bretonniere, Claire; Vercelletto, Martine; Gabelle, Audrey; Le Ber, Isabelle; Honda, Tadashi; Dinkova-Kostova, Albena T.; Hardy, John; Carro, Eva; Abramov, Andrey Y.

In: Scientific Reports, Vol. 7, No. 1, 1666, 01.12.2017.

Research output: Contribution to journalArticle

Bartolome, F, Esteras, N, Martin-Requero, A, Boutoleau-Bretonniere, C, Vercelletto, M, Gabelle, A, Le Ber, I, Honda, T, Dinkova-Kostova, AT, Hardy, J, Carro, E & Abramov, AY 2017, 'Pathogenic p62/SQSTM1 mutations impair energy metabolism through limitation of mitochondrial substrates', Scientific Reports, vol. 7, no. 1, 1666. https://doi.org/10.1038/s41598-017-01678-4
Bartolome F, Esteras N, Martin-Requero A, Boutoleau-Bretonniere C, Vercelletto M, Gabelle A et al. Pathogenic p62/SQSTM1 mutations impair energy metabolism through limitation of mitochondrial substrates. Scientific Reports. 2017 Dec 1;7(1). 1666. https://doi.org/10.1038/s41598-017-01678-4
Bartolome, Fernando ; Esteras, Noemi ; Martin-Requero, Angeles ; Boutoleau-Bretonniere, Claire ; Vercelletto, Martine ; Gabelle, Audrey ; Le Ber, Isabelle ; Honda, Tadashi ; Dinkova-Kostova, Albena T. ; Hardy, John ; Carro, Eva ; Abramov, Andrey Y. / Pathogenic p62/SQSTM1 mutations impair energy metabolism through limitation of mitochondrial substrates. In: Scientific Reports. 2017 ; Vol. 7, No. 1.
@article{0caaaebf09054c94a2a30a4d1769f948,
title = "Pathogenic p62/SQSTM1 mutations impair energy metabolism through limitation of mitochondrial substrates",
abstract = "Abnormal mitochondrial function has been found in patients with frontotemporal dementia (FTD) and amyotrophic lateral sclerosis (ALS). Mutations in the p62 gene (also known as SQSTM1) which encodes the p62 protein have been reported in both disorders supporting the idea of an ALS/FTD continuum. In this work the role of p62 in energy metabolism was studied in fibroblasts from FTD patients carrying two independent pathogenic mutations in the p62 gene, and in a p62-knock-down (p62 KD) human dopaminergic neuroblastoma cell line (SH-SY5Y). We found that p62 deficiency is associated with inhibited complex I mitochondrial respiration due to lack of NADH for the electron transport chain. This deficiency was also associated with increased levels of NADPH reflecting a higher activation of pentose phosphate pathway as this is accompanied with higher cytosolic reduced glutathione (GSH) levels. Complex I inhibition resulted in lower mitochondrial membrane potential and higher cytosolic ROS production. Pharmacological activation of transcription factor Nrf2 increased mitochondrial NADH levels and restored mitochondrial membrane potential in p62-deficient cells. Our results suggest that the phenotype is caused by a loss-of-function effect, because similar alterations were found both in the mutant fibroblasts and the p62 KD model. These findings highlight the implication of energy metabolism in pathophysiological events associated with p62 deficiency.",
author = "Fernando Bartolome and Noemi Esteras and Angeles Martin-Requero and Claire Boutoleau-Bretonniere and Martine Vercelletto and Audrey Gabelle and {Le Ber}, Isabelle and Tadashi Honda and Dinkova-Kostova, {Albena T.} and John Hardy and Eva Carro and Abramov, {Andrey Y.}",
year = "2017",
month = "12",
day = "1",
doi = "10.1038/s41598-017-01678-4",
language = "English (US)",
volume = "7",
journal = "Scientific Reports",
issn = "2045-2322",
publisher = "Nature Publishing Group",
number = "1",

}

TY - JOUR

T1 - Pathogenic p62/SQSTM1 mutations impair energy metabolism through limitation of mitochondrial substrates

AU - Bartolome, Fernando

AU - Esteras, Noemi

AU - Martin-Requero, Angeles

AU - Boutoleau-Bretonniere, Claire

AU - Vercelletto, Martine

AU - Gabelle, Audrey

AU - Le Ber, Isabelle

AU - Honda, Tadashi

AU - Dinkova-Kostova, Albena T.

AU - Hardy, John

AU - Carro, Eva

AU - Abramov, Andrey Y.

PY - 2017/12/1

Y1 - 2017/12/1

N2 - Abnormal mitochondrial function has been found in patients with frontotemporal dementia (FTD) and amyotrophic lateral sclerosis (ALS). Mutations in the p62 gene (also known as SQSTM1) which encodes the p62 protein have been reported in both disorders supporting the idea of an ALS/FTD continuum. In this work the role of p62 in energy metabolism was studied in fibroblasts from FTD patients carrying two independent pathogenic mutations in the p62 gene, and in a p62-knock-down (p62 KD) human dopaminergic neuroblastoma cell line (SH-SY5Y). We found that p62 deficiency is associated with inhibited complex I mitochondrial respiration due to lack of NADH for the electron transport chain. This deficiency was also associated with increased levels of NADPH reflecting a higher activation of pentose phosphate pathway as this is accompanied with higher cytosolic reduced glutathione (GSH) levels. Complex I inhibition resulted in lower mitochondrial membrane potential and higher cytosolic ROS production. Pharmacological activation of transcription factor Nrf2 increased mitochondrial NADH levels and restored mitochondrial membrane potential in p62-deficient cells. Our results suggest that the phenotype is caused by a loss-of-function effect, because similar alterations were found both in the mutant fibroblasts and the p62 KD model. These findings highlight the implication of energy metabolism in pathophysiological events associated with p62 deficiency.

AB - Abnormal mitochondrial function has been found in patients with frontotemporal dementia (FTD) and amyotrophic lateral sclerosis (ALS). Mutations in the p62 gene (also known as SQSTM1) which encodes the p62 protein have been reported in both disorders supporting the idea of an ALS/FTD continuum. In this work the role of p62 in energy metabolism was studied in fibroblasts from FTD patients carrying two independent pathogenic mutations in the p62 gene, and in a p62-knock-down (p62 KD) human dopaminergic neuroblastoma cell line (SH-SY5Y). We found that p62 deficiency is associated with inhibited complex I mitochondrial respiration due to lack of NADH for the electron transport chain. This deficiency was also associated with increased levels of NADPH reflecting a higher activation of pentose phosphate pathway as this is accompanied with higher cytosolic reduced glutathione (GSH) levels. Complex I inhibition resulted in lower mitochondrial membrane potential and higher cytosolic ROS production. Pharmacological activation of transcription factor Nrf2 increased mitochondrial NADH levels and restored mitochondrial membrane potential in p62-deficient cells. Our results suggest that the phenotype is caused by a loss-of-function effect, because similar alterations were found both in the mutant fibroblasts and the p62 KD model. These findings highlight the implication of energy metabolism in pathophysiological events associated with p62 deficiency.

UR - http://www.scopus.com/inward/record.url?scp=85019197514&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85019197514&partnerID=8YFLogxK

U2 - 10.1038/s41598-017-01678-4

DO - 10.1038/s41598-017-01678-4

M3 - Article

C2 - 28490746

AN - SCOPUS:85019197514

VL - 7

JO - Scientific Reports

JF - Scientific Reports

SN - 2045-2322

IS - 1

M1 - 1666

ER -